Top U.S. lawmakers on Tuesday wrote to Google's chief executive raising concerns about reports of a massive database known as Sensorvault that allegedly contains precise consumer location information from hundreds of millions of devices.

The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy.

AbbVie Inc said on Tuesday that the U.S. Food and Drug Administration approved its Skyrizi drug as a treatment for plaque psoriasis at a time when its blockbuster psoriasis drug, Humira, faces patent pressures.

The top Democrats and Republicans on the U.S. House Energy and Commerce Committee on Tuesday wrote Google Chief Executive Sundar Pichai raising concerns about reports of a massive database of precise consumer location information on hundreds of millions of consumers known as "Sensorvault."

Four of the largest U.S. beef-packing companies were accused in a lawsuit on Tuesday of violating federal antitrust law by conspiring to drive down prices they paid ranchers for cattle, even as retail beef prices hovered near record levels.

The U.S. Federal Reserve on Tuesday proposed a framework for determining when a company has taken control of a bank and must face more rigorous oversight and restrictions, a move that could remove hurdles for banks seeking to attract investors and partners.

Britain's competition regulator said on Tuesday it expected to publish its final report on supermarket group Sainsbury's proposed 7.3 billion pound ($9.4 billion) takeover of Walmart-owned rival Asda on Thursday, April 25.

General Electric Co on Tuesday put the remnants of its WMC Mortgage unit into bankruptcy, 11 days after paying a $1.5 billion U.S. fine over defective subprime mortgages issued by WMC before the 2008 financial crisis.

Britain's competition regulator said on Tuesday it expected to publish its final report on supermarket group Sainsbury's proposed takeover of Walmart-owned rival Asda on Thursday, April 25.

Teva Pharmaceutical Industries Ltd said on Tuesday it would stop developing its migraine drug, Ajovy, for treating cluster headaches after the company found the treatment was unlikely to meet the main goal of a late-stage trial.